She’s since switched to an online provider and has now been on tirzepatide for about two years (with a brief stint on compounded semaglutide, because she was concerned about losing access to her ...

Demand for glucagon-like peptide-1 weight-loss drugs — such as Ozempic, Zepbound and Wegovy — coupled with limited insurance ...

Why one man — and others in his gray market community — is making tirzepatide at home. Insurance wouldn't cover his weight loss medication. So he started making his own.

Discussing Tirzepatide’s Rise in Diabetes, Obesity Care: Jaime Almandoz, MD, MBA Can Medicare Sustain Widespread Access to GLP-1 Therapies? The mean (SD) overall patient age was 51.8 (17.6) years.

INDIANAPOLIS – The way people are accessing GLP-1 medications Semaglutide and Tirzepatide is going to become very limited after the drugs were taken off the FDA’s shortage list. Hundreds of ...

Tirzepatide and Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist and is only available with a doctor’s prescription and needs to be injected on a regular basis.

So as of now, 503As can’t compound tirzepatide (at least on the basis of its being in shortage), since we’re past the February 18 deadline; and 503Bs have until March 19 to call it quits.

In a statement posted to the newsroom of Hims & Hers (HIMS), Craig Primack stated in part: “In my experience of treating thousands of people ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to halt the sale and production of off-brand products that many patients ...

The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to cheaper versions could end.

INDIANAPOLIS – The way people are accessing GLP-1 medications Semaglutide and Tirzepatide is going to become very limited after the drugs were taken off the FDA’s shortage list.